These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
832 related articles for article (PubMed ID: 20698860)
1. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling. Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860 [TBL] [Abstract][Full Text] [Related]
2. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction]. Han YL; Cheng C; Tan HM; Wu WK; Wu YL; Sun HL; Sun J; Chen JL Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270 [TBL] [Abstract][Full Text] [Related]
3. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125 [TBL] [Abstract][Full Text] [Related]
4. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca Ji XW; Lyu HJ; Zhou GH; Wu B; Zhu YY; Wu TH; Zhang F; Jin SN; Cho KW; Wen JF Phytomedicine; 2021 Jan; 81():153410. PubMed ID: 33285470 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B. Sharma S; Singh M; Sharma PL Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535 [TBL] [Abstract][Full Text] [Related]
7. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. Wang S; Wright G; Harrah J; Touchon R; McCumbee W; Geng W; Fultz ME; Abdul-Jalil MN; Wright GL Can J Physiol Pharmacol; 2000 Jun; 78(6):500-6. PubMed ID: 10914640 [TBL] [Abstract][Full Text] [Related]
8. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. Zhang BQ; Hu SJ; Qiu LH; Zhu JH; Xie XJ; Sun J; Zhu ZH; Xia Q; Bian K Vascul Pharmacol; 2007 Apr; 46(4):278-85. PubMed ID: 17196887 [TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Lan TH; Xu ZW; Wang Z; Wu YL; Wu WK; Tan HM Biochem Pharmacol; 2011 Jul; 82(2):148-55. PubMed ID: 21515242 [TBL] [Abstract][Full Text] [Related]
10. Homocysteine reduces protein S-nitrosylation in endothelium. Chen Y; Zhao S; Wang Y; Li Y; Bai L; Liu R; Fan J; Liu E Int J Mol Med; 2014 Nov; 34(5):1277-85. PubMed ID: 25189662 [TBL] [Abstract][Full Text] [Related]
12. Phytoestrogen α-zearalanol improves vascular function in ovariectomized hyperhomocysteinemic rats. Zhen PP; Duan JH; Zhao Q; Hou DD; Wang HX; Hong N; Zhen HX; Wang W Atherosclerosis; 2011 Apr; 215(2):309-15. PubMed ID: 21292265 [TBL] [Abstract][Full Text] [Related]
13. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/Akt pathway in rat aorta. Toba H; Gomyo E; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Asayama J; Kobara M; Nakata T Clin Exp Pharmacol Physiol; 2006; 33(5-6):440-7. PubMed ID: 16700876 [TBL] [Abstract][Full Text] [Related]
14. The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine. Xu Z; Lan T; Wu W; Wu Y J Vasc Surg; 2011 Jan; 53(1):156-64. PubMed ID: 20801605 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation. Santhanam AV; Viswanathan S; Dikshit M Eur J Pharmacol; 2007 Oct; 572(2-3):189-96. PubMed ID: 17640632 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia. Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583 [TBL] [Abstract][Full Text] [Related]
18. Endothelial cell dysfunction in a model of oxidative stress. Jin L; Abou-Mohamed G; Caldwell RB; Caldwell RW Med Sci Monit; 2001; 7(4):585-91. PubMed ID: 11433181 [TBL] [Abstract][Full Text] [Related]
19. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Shukla N; Koupparis A; Jones RA; Angelini GD; Persad R; Jeremy JY Eur J Pharmacol; 2006 Feb; 531(1-3):201-8. PubMed ID: 16451799 [TBL] [Abstract][Full Text] [Related]
20. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]